AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

Japan · Delayed Price · Currency is JPY

832.00

+4.00 (0.48%)

Jun 26, 2026, 3:30 PM JST

-3.48% (1Y)

Market Cap	12.11B -0.2%
Revenue (ttm)	32.89B +2.0%
Net Income	1.37B -8.3%
EPS	96.23 -9.2%
Shares Out	14.56M
PE Ratio	8.65
Forward PE	n/a
Dividend	36.00 (4.33%)
Ex-Dividend Date	Aug 28, 2026

Volume	12,500
Open	827.00
Previous Close	828.00
Day's Range	827.00 - 832.00
52-Week Range	810.00 - 918.00
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 15, 2026

About AFC-HD AMS Life Science

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs,... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 1969

Employees 1,008

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 2927

Full Company Profile

Financial Performance

In fiscal year 2025, AFC-HD AMS Life Science's revenue was 32.66 billion, an increase of 8.18% compared to the previous year's 30.19 billion. Earnings were 1.45 billion, an increase of 15.65%.

Financial Statements